Assignee
MIRECULE INC
US·3 granted patents·5 pending applications·1 citations·filing 2021–2024
Top patents by PatentIndex Score
8 records- 0186US12104157B2Targeted inhibition using engineered oligonucleotidesMIRECULE INC·Filed 2023·Granted Oct 1, 2024·1 cites·30 claims
- 0277US2024141346A1Targeted inhibition using engineered oligonucleotidesMIRECULE INC·Filed 2023·Application pending·0 cites
- 0373US11597930B2Targeted inhibition using engineered oligonucleotidesMIRECULE INC·Filed 2022·Granted Mar 7, 2023·0 cites·16 claims
- 0472US11795459B2Targeted inhibition using engineered oligonucleotidesMIRECULE INC·Filed 2022·Granted Oct 24, 2023·0 cites·24 claims
- 0566US2023132602A1Targeted Inhibition Using Engineered OligonucleotidesMIRECULE INC·Filed 2021·Application pending·0 cites
- 0663US2024271134A1Oligonucleotides and compositions thereof for neuromuscular disordersMIRECULE INC·Filed 2024·Application pending·0 cites
- 0762US2025025569A1Tissue-specific imaging and therapeutic agents targeting proteins expressed on muscle cell surfaceMIRECULE INC·Filed 2024·Application pending·0 cites
- 0859US2025127912A1Compositions for delivery of polynucleotidesMIRECULE INC·Filed 2024·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →